Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Pyrimethamine
Drug ID BADD_D01886
Description One of the folic acid antagonists that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis.
Indications and Usage For the treatment of toxoplasmosis and acute malaria; For the prevention of malaria in areas non-resistant to pyrimethamine
Marketing Status Prescription
ATC Code P01BD01
DrugBank ID DB00205
KEGG ID D00488
MeSH ID D011739
PubChem ID 4993
TTD Drug ID D0C0SK
NDC Product Code 51927-0103; 0480-3720; 43598-672; 72647-330; 60592-244; 57451-1183; 66651-922; 64677-0006; 47781-925; 51927-3122; 67763-114; 68057-001; 63804-5300; 51927-0237; 69413-330; 48102-026; 59651-564; 71052-215; 40074-0008; 71554-020
Synonyms Pyrimethamine | Malocide | Tindurine | Chloridin | Daraprim
Chemical Information
Molecular Formula C12H13ClN4
CAS Registry Number 58-14-0
SMILES CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pancytopenia01.03.03.003--Not Available
Phenylketonuria03.08.04.002; 20.02.01.018; 19.21.06.002; 17.03.07.002; 14.14.04.002--Not Available
Platelet count decreased13.01.04.0010.000466%
Pneumonia22.07.01.003; 11.01.09.0030.000466%Not Available
Premature baby18.04.02.0010.000699%Not Available
Pruritus23.03.12.0010.000932%
Pulmonary congestion24.03.08.001; 22.01.03.002; 02.05.02.0020.000122%Not Available
Pulmonary eosinophilia22.01.01.009; 01.02.04.006--Not Available
Pyrexia08.05.02.0030.000699%
Rash23.03.13.0010.000466%Not Available
Rash papular23.03.13.0170.000466%Not Available
Seizure17.12.03.0010.001165%
Somnolence19.02.05.003; 17.02.04.0060.000699%
Stevens-Johnson syndrome11.07.01.005; 10.01.03.020; 23.03.01.007; 12.03.01.014--
Thrombocytopenia01.08.01.0020.000466%Not Available
Toxic epidermal necrolysis23.03.01.008; 12.03.01.015; 11.07.01.006; 10.01.01.006--
Urticaria23.04.02.001; 10.01.06.0010.000466%
Ventricular fibrillation02.03.04.0080.000122%
Vomiting07.01.07.0030.002563%
White blood cell count decreased13.01.06.0120.000466%
Central nervous system lesion17.02.10.0110.000466%Not Available
Acute coronary syndrome24.04.04.011; 02.02.02.0150.000122%Not Available
Pruritus generalised23.03.12.0030.000466%Not Available
Decreased appetite14.03.01.005; 08.01.09.0280.000932%
Blood disorder01.05.01.004--Not Available
Bone marrow failure01.03.03.0050.000365%
Atrophic glossitis07.14.01.004--Not Available
Drug reaction with eosinophilia and systemic symptoms23.03.05.005; 10.01.01.0210.000699%Not Available
Maternal drugs affecting foetus12.03.03.006; 18.03.03.0090.001165%Not Available
Spleen congestion01.09.02.0050.000466%Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages